Analyst price target range
Genmab Price Target: $39.14 Average
Direct answer
Genmab's average price target is $39.14.
The verified analyst range runs from $32.00 to $45.00.
The low target implies -7.9%, the high target implies +29.5%, and the range spans 37.4% of the current price.
Forecast evidence checked September 19, 2026.
Get free Genmab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $34.74
- Average price target
- $39.14
- High price target
- $45.00
- Low price target
- $32.00
- Low target gap
- -7.9%
- Target upside
- +12.7%
- High target gap
- +29.5%
- Target range width
- 37.4%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- September 19, 2026
- Valid through
- September 26, 2026
Explore related company data
Read the frequently asked questions.
What is Genmab's average price target?
Genmab's verified average price target is $39.14. The target range is $32.00 to $45.00.
How far are Genmab's low and high targets from the recorded price?
The low target implies -7.9%, while the high target implies +29.5%.
How many analysts are included in Genmab's consensus?
The verified consensus includes 11 analysts.
How is Genmab's target upside or downside calculated?
The average target of $39.14 is divided by the recorded price of $34.74, then one is subtracted to produce +12.7%. This does not guarantee a future return.
When was Genmab's analyst forecast verified?
The data was verified on 2026-09-19. The dataset is valid through 2026-09-26.